The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma.

Zhao, Yi-Lei; Yang, Li-Bin; Geng, Xiao-Lin; Zhou, Qing-Lan; Qin, Hua; Yang, Lin; Dong, Yu-Zhen; Zhong, Jin-Jie

Zhao, Yi-Lei; Yang, Li-Bin; Geng, Xiao-Lin; Zhou, Qing-Lan; Qin, Hua; Yang, Lin; Dong, Yu-Zhen; Zhong, Jin-Jie.

Afiliación

Zhao YL; Yi-lei Zhao, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Yang LB; Li-bin Yang, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Geng XL; Xiao-lin Geng, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Zhou QL; Qing-lan Zhou, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Qin H; Hua Qin, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Yang L; Lin Yang, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Dong YZ; Yu-zhen Dong, Department of Orthopedic Surgery, the First Affiliated Hospital, Xinxiang Medical College, Xinxiang, China.
Zhong JJ; Jin-Jie Zhong, Department of Histology & Embryology, Xinjiang Medical University, 393 Xinyi Road, Urumqi, China.

Pak J Med Sci ; 29(5): 1225-9, 2013 Sep.

Article en En | MEDLINE | ID: mdl-24353725

Palabras clave

Clinical outcome; MMS19L; Osteosarcoma; XPG

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pak J Med Sci Año: 2013 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google